What might be less obvious is how the drug is affecting your brain
They are not experiencing severe hypoglycemic events or unexpected adverse events, there are no signs of the body rejecting the transplanted cells, and there are no signs of kidney toxicity
Alternatives include other GLP-1 receptor agonists (such as dulaglutide or liraglutide), SGLT2 inhibitors (such as dapagliflozin or empagliflozin), DPP-4 inhibitors, or insulin therapy
In the United States, 10.5% of the population has diabetes, with about 9095% of those having T2D [2]
Neither compound is orally bioavailable in these formulations
After delivery, semaglutide can be restarted if the patient is not breastfeeding, under medical supervision